share_log

Teladoc Health | 10-Q: Q3 2024 Earnings Report

Teladoc Health | 10-Q: Q3 2024 Earnings Report

Teladoc Health | 10-Q：2024财年三季报
美股SEC公告 ·  2024/10/31 22:25

Moomoo AI 已提取核心信息

Teladoc Health reported Q3 2024 revenue of $640.5 million, down 3% year-over-year, primarily due to weakness in its BetterHelp segment. The company's net loss narrowed to $33.3 million from $57.1 million in Q3 2023. Access fees, representing 87% of total revenue, declined 5% to $555.3 million, while other revenue increased 9% to $85.2 million.The Integrated Care segment showed resilience with revenue growing 2% to $383.7 million, driven by higher U.S. visit revenue and strong international growth. U.S. Integrated Care members increased 4% to 93.9 million. However, the BetterHelp segment struggled with revenue falling 10% to $256.8 million as average monthly paying users decreased 13% to 398,000.The company maintained strong liquidity with $1.24 billion in cash and cash equivalents as of September 30, 2024. Operating cash flow remained positive at $207.8 million for the nine months ended September 30, 2024. Management expects continued positive operating cash flow results for 2024, with sufficient resources to meet working capital needs for at least the next 12 months.
Teladoc Health reported Q3 2024 revenue of $640.5 million, down 3% year-over-year, primarily due to weakness in its BetterHelp segment. The company's net loss narrowed to $33.3 million from $57.1 million in Q3 2023. Access fees, representing 87% of total revenue, declined 5% to $555.3 million, while other revenue increased 9% to $85.2 million.The Integrated Care segment showed resilience with revenue growing 2% to $383.7 million, driven by higher U.S. visit revenue and strong international growth. U.S. Integrated Care members increased 4% to 93.9 million. However, the BetterHelp segment struggled with revenue falling 10% to $256.8 million as average monthly paying users decreased 13% to 398,000.The company maintained strong liquidity with $1.24 billion in cash and cash equivalents as of September 30, 2024. Operating cash flow remained positive at $207.8 million for the nine months ended September 30, 2024. Management expects continued positive operating cash flow results for 2024, with sufficient resources to meet working capital needs for at least the next 12 months.
Teladoc Health报告2024年第三季度营业收入为64050万美元，同比下降3%，主要由于BetterHelp部门的疲软。公司的净亏损从2023年第三季度的5710万美元收窄至3330万美元。占总营业收入87%的接入费用下降5%，降至55530万美元，而其他营业收入增长9%，达到8520万美元。综合护理部门表现出韧性，营业收入增长2%，达到38370万美元，得益于美国就诊收入增加和强劲的国际增长。美国综合护理成员增加4%，达9390万。然而，BetterHelp部门表现不佳，营业收入下降10%，降至25680万美元，平均月付费用户下降13%，降至398,000。截至2024年9月30日，公司保持强劲的流动性，现金及现金等价物为12.4亿。2024年9月30日结束的九个月内，经营现金流仍为正，达到20780万美元。管理层预计2024年将继续保持正的经营现金流，拥有足够的资源以满足未来至少12个月的营运资金需求。
Teladoc Health报告2024年第三季度营业收入为64050万美元，同比下降3%，主要由于BetterHelp部门的疲软。公司的净亏损从2023年第三季度的5710万美元收窄至3330万美元。占总营业收入87%的接入费用下降5%，降至55530万美元，而其他营业收入增长9%，达到8520万美元。综合护理部门表现出韧性，营业收入增长2%，达到38370万美元，得益于美国就诊收入增加和强劲的国际增长。美国综合护理成员增加4%，达9390万。然而，BetterHelp部门表现不佳，营业收入下降10%，降至25680万美元，平均月付费用户下降13%，降至398,000。截至2024年9月30日，公司保持强劲的流动性，现金及现金等价物为12.4亿。2024年9月30日结束的九个月内，经营现金流仍为正，达到20780万美元。管理层预计2024年将继续保持正的经营现金流，拥有足够的资源以满足未来至少12个月的营运资金需求。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

独立文件4  查看翻译

独立文件5  查看翻译

独立文件6  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    Performant Healthcare
    PHLT
    -- 3.000
    SHL Telemedicine
    SHLT
    -- 1.950
    Simulations Plus
    SLP
    -- 24.290
    Mangoceuticals
    MGRX
    -- 2.380
    Forian
    FORA
    -- 2.000
    解锁完整榜单
    重估中国资产
    继中国开创性的DeepSeek技术推出之后， 华尔街大行重估对中国市场的投资前景。
    热门讨论
    FOMC维持利率但不确定性高企：美股后市走向如何？
    🎙️讨论 1. 美联储强调政策路径存在“高度不确定性”，你更关注利率预期变化还是经济数据对市场的短期影响？ 2. 若核心通胀维持高位，哪类板块更具交易机会——防御型股票还是科技成长股？ 展开
    联邦公开市场委员会新闻发布会，2025年3月19日